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“When antibiotics became industrially produced following World War II, our quality of 
life and our longevity improved enormously. No one thought bacteria were going to 
become resistant.”  
-Bonnie Bassler 
 
A New Class of Antibiotics Could Stop Drug-Resistant Bacteria in their Tracks 
 
Antibiotics, among the most commonly prescribed drugs in the world, are becoming 
increasingly ineffective against a growing number of multi drug-resistant strains of bacteria. 
Bacteria can become resistant to antibiotics in a few different ways. Commonly, patients 
prescribed with these life-saving drugs do not complete a prescription regiment. This allows the 
bacteria, which were not killed by the antibiotics initially, to gain tolerance to the drugs. These 
‘tolerant’ bacteria then reproduce and, if treatments resume, will be resistant to the antibiotics. 
According to the Centers for Disease Control and Prevention, over 2 million people become 
infected with antibiotic-resistant bacteria and 23,000 people die as a direct result of these 
infections in the United States alone. To combat this issue, scientists around the world have been 
searching for new, creative approaches to combat bacterial resistance. 
Bacteria, among earth’s first life forms, are microscopic organisms that have developed a 
powerful array of techniques to survive in some of the world’s harshest environments. 
Unbeknownst to most, these seemingly mundane little beings actually communicate with one 
another in much the same way that people talk over the telephone. If I wanted to contact a friend 
in Bangladesh, for example, I would dial his phone number, thus sending out a specific signal. 
My friend across the Pacific, recognizing my unique phone number, would (hopefully) answer 
the phone. Telephone communication thus requires that I understand both my friend’s phone 
number and, if I want my friend to answer when I call, that I possess an identifying phone 
number of my own. This simple logic aptly describes the manner in which many of our 
microscopic counterparts communicate. 
In 2009, Dr. Bonnie Bassler gained international renown with her TED talk entitled 
“How bacteria ‘talk.’” As a world-renowned American molecular biologist and 2002 MacArthur 
Fellow, Bassler has been instrumental in advancing our understanding of "quorum sensing," a 
fancy term for the way that bacteria communicate with one another.  
 
 
Bacteria synthesize and release chemicals at an astounding pace. These same bacteria 
also possess a receptor that recognizes, and binds to, the chemicals that they themselves have 
released. Every species of bacteria releases a different chemical and has a unique receptor which 
binds to their own identifying chemical. Essentially, bacteria of the same species have the same 
"area code," which allows them to recognize their "family" when placed among many different 
species. As the numbers of bacteria grow on a petri dish or within the human body, these 
receptors become more and more activated. When the number of chemicals surrounding the 
bacteria increase over a certain threshold, it indicates to the bacteria that there are members of 
the same species nearby. When these bacteria sense that there are enough of their species in the 
same area, they may attack the host or form a biofilm, both of which can result in dangerous 
infections or disease. This simple communication principle lies at the heart of quorum sensing 
and is depicted in the cartoon image below. 
  
 
 
By analyzing the unique chemical signals, or "area codes," of different bacteria, the 
Bassler lab has created an exciting class of antibiotics aptly named "quorum sensing inhibitors." 
These are drugs that block the way bacteria communicate by cutting off their landline. To create 
these quorum sensing inhibitors, a few key steps are involved. The scientists begin by creating a 
drug that looks similar to the chemicals that the bacteria normally release on their own. The 
quorum sensing inhibitors must bind to the same receptors that the normal chemicals do. The 
main difference between the drugs made in the Bassler lab and the chemicals that the bacteria 
normally release, however, is that the artificial inhibitors attach to the bacterial receptors and 
never let go, thus blocking their communication system and putting the receptor out of business. 
If enough of these quorum sensing inhibitors are present, every bacterial communication receptor 
will be down for the count, and the bacteria will be unable to recognize and communicate with 
nearby members of their species. This lack of communication prevents the bacteria from 
gathering enough forces to attack the host or form a dangerous biofilm. 
 In a research study published in the journal Proceedings of the National Academy of 
Sciences, the Bassler laboratory successfully created a compound that blocks the communication 
of Pseudomonas aeruginosa, a largely antibiotic-resistant strain of bacteria that commonly 
causes hospital infections by forming dense biofilms in a host. Biofilms are essentially large 
colonies of bacterial growth that are difficult to get rid of and cost the healthcare industry billions 
of dollars each year. Biofilms of P. aeruginosa can be found on catheters and cardiac stents after 
surgery. Consequently, patients are at increased risk for infection and must pay to replace these 
devices every couple of years. 
 The compound that the Bassler Laboratory created to block P. aeruginosa 
communication is called meta-bromo-thiolactone (or mBTL for short). mBTL has a structure 
similar to the chemical that P. aeruginosa normally uses to communicate and proved effective in 
targeting two very important P. aeruginosa communication receptors. It was able to bind and 
deactivate both of these receptors and prevent signaling molecules from entering the receptor 
sites, thus cutting off P. aeruginosa signaling. 
 This scientific breakthrough may be the foundation upon which a new class of antibiotics 
are created. With alternative antibiotics available to combat these pesky microbes, doctors will 
have access to more options for patient treatment without jeopardizing community health.  
